86 related articles for article (PubMed ID: 3725023)
1. [Control of platelet antiaggregation therapy using an electronic aggregometer on whole blood].
Arpaia MR; Leonardo G; del Guercio R
Minerva Cardioangiol; 1986 Apr; 34(4):195-8. PubMed ID: 3725023
[No Abstract] [Full Text] [Related]
2. [Platelet release proteins in plasma in peripheral arterial obliterative disease during ticlopidine administration].
Klingemann HG; Egbring R
Dtsch Med Wochenschr; 1982 Sep; 107(37):1388-91. PubMed ID: 7117151
[No Abstract] [Full Text] [Related]
3. [The antiaggregation effect of ticlopidine on blood platelets preliminary results and prospectives for studies in various diseases].
Andriani A; Chiappetta MG; Fabiani M; Mosiello G; Beni A
Clin Ter; 1983 Feb; 104(3):219-22. PubMed ID: 6345050
[No Abstract] [Full Text] [Related]
4. [Evaluation of platelet aggregation in patients treated with ticlopidine].
Sbalzarini G; Carniti E; Fiorini L; Iezzi BG
Clin Ter; 1984 Nov; 111(3):247-50. PubMed ID: 6240365
[No Abstract] [Full Text] [Related]
5. Therapeutic effect of ticlopidine for ischemic leg ulcers.
Katsumura T
Agents Actions Suppl; 1984; 15():167-72. PubMed ID: 6385645
[No Abstract] [Full Text] [Related]
6. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
Wong S; Morel-Kopp MC; Chen Q; Appleberg M; Ward CM; Lewis DR
Thromb Haemost; 2006 Jun; 95(6):1042-3. PubMed ID: 16732389
[No Abstract] [Full Text] [Related]
7. Therapeutic effect of ticlopidine, a new inhibitor of platelet aggregation, on chronic arterial occlusive diseases, a double-blind study versus placebo.
Katsumura T; Mishima Y; Kamiya K; Sakaguchi S; Tanabe T; Sakuma A
Angiology; 1982 Jun; 33(6):357-67. PubMed ID: 7046521
[TBL] [Abstract][Full Text] [Related]
8. The effect of ticlopidine on platelet functions in acute myocardial infarction. A double blind controlled trial.
Knudsen JB; Kjøller E; Skagen K; Gormsen J
Thromb Haemost; 1985 Jun; 53(3):332-6. PubMed ID: 3901391
[TBL] [Abstract][Full Text] [Related]
9. The influence of ticlopidine on the natural course of retinal vein occlusion.
Houtsmuller AJ; Vermeulen JA; Klompe M; Zahn KJ; Henkes HE; Baarsma GS; Tijssen J
Agents Actions Suppl; 1984; 15():219-29. PubMed ID: 6385648
[TBL] [Abstract][Full Text] [Related]
10. [The effects of ticlopidine on platelet aggregation: study on 13 atherosclerotic patients].
Lenci R; Galante A; Borzi M; Ariganello M; Sommariva L; Filice A; Cannata D
Clin Ter; 1983 Feb; 104(3):205-9. PubMed ID: 6861457
[No Abstract] [Full Text] [Related]
11. A platelet aggregation inhibitor--ticlopidine--in diabetic nephropathy: a randomized double blind study.
Nyberg G; Larsson O; Westberg NG; Aurell M; Jagenburg R; Blohmé G
Clin Nephrol; 1984 Mar; 21(3):184-7. PubMed ID: 6705280
[TBL] [Abstract][Full Text] [Related]
12. [Anti-platelet aggregation action and paradoxical effects of acetylsalicylic acid].
Mocchi N; Sbalzarini G; Cantaluppi P
Clin Ter; 1985 Jul; 114(1):37-41. PubMed ID: 4042578
[No Abstract] [Full Text] [Related]
13. Effects of ticlopidine of platelet function in men with stable angina pectoris.
Berglund U; von Schenck H; Wallentin L
Thromb Haemost; 1985 Dec; 54(4):808-12. PubMed ID: 3911481
[TBL] [Abstract][Full Text] [Related]
14. Overview: clinical experiences with ticlopidine.
Day HJ
Agents Actions Suppl; 1984; 15():297-309. PubMed ID: 6385654
[No Abstract] [Full Text] [Related]
15. The light-scattering whole blood aggregometer: a novel device for assessment of platelet aggregation in undiluted blood.
Zheng Y; Solen KA; Mohammad SF
Arch Pathol Lab Med; 1998 Oct; 122(10):880-6. PubMed ID: 9786348
[TBL] [Abstract][Full Text] [Related]
16. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
Maksimović ZV
Srp Arh Celok Lek; 1999; 127(7-8):249-53. PubMed ID: 10624398
[TBL] [Abstract][Full Text] [Related]
17. [Study on the relationship of plasma fibrinogen, platelet aggregation rate and peripheral arterial occlusive disease].
Wang J; Li XY; He Y; Ni B
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jan; 26(1):1-4. PubMed ID: 15921581
[TBL] [Abstract][Full Text] [Related]
18. [Acute coronary syndrome, stroke, arterial occlusive disease. Bring the patients out of the danger zone!].
Füessl HS
MMW Fortschr Med; 2004; 146 Suppl 1():3. PubMed ID: 15493407
[No Abstract] [Full Text] [Related]
19. Response to aspirin and clopidogrel monitored with different platelet function methods.
Mani H; Linnemann B; Luxembourg B; Kirchmayr K; Lindhoff-Last E
Platelets; 2006 Aug; 17(5):303-10. PubMed ID: 16928602
[TBL] [Abstract][Full Text] [Related]
20. [Effect of ticlopidine on peripheral obliterating arteriopathy].
Stiegler H; Hess H; Mietaschk A; Trampisch HJ; Ingrisch H
Dtsch Med Wochenschr; 1984 Aug; 109(33):1240-3. PubMed ID: 6381015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
